What Information Should Be Required to Support Clinical "Omics" Publications?
about
Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situA structured approach to predictive modeling of a two-class problem using multidimensional data setsProteomics and metabolomics in renal transplantation-quo vadis?Hands-on workshops as an effective means of learning advanced technologies including genomics, proteomics and bioinformaticsComparability and reproducibility of biomedical dataReuse of public genome-wide gene expression dataFAST: FAST Analysis of Sequences Toolbox.Detecting disease variants in case-parent trio studies using the bioconductor software package trioClinical trials in the era of personalized oncology.Inter-Laboratory Variability in Array-Based RNA Quantification Methods.The evolving role of the pathologist in the management of lung cancer.Use of semantic workflows to enhance transparency and reproducibility in clinical omics.Predicting outcomes in radiation oncology--multifactorial decision support systemsWhere in the genome are we? A cautionary tale of database use in genomics research.Independent validation of a model using cell line chemosensitivity to predict response to therapy.microRNAs in colon cancer: a roadmap for discovery.Research ethics in the post-genomic era.The EGAPP initiative: lessons learned.Developing translational research infrastructure and capabilities associated with cancer clinical trials.More data, please!Precision medicine for cancer patients: lessons learned and the path forward.Toward the Geoscience Paper of the Future: Best practices for documenting and sharing research from data to software to provenanceDataPackageR: Reproducible data preprocessing, standardization and sharing using R/Bioconductor for collaborative data analysisStatistics: a data science for the 21st century
P2860
Q26864448-5C50A5FE-544D-4F6B-8957-D699B5C55B81Q27022220-F4A299AD-CFC0-4D3A-ADF9-EFB2FC8CDF43Q27024418-D45974A4-475D-446A-9450-2B33497F1F5FQ28387396-17D9B8AD-3B3F-436B-8399-B7C33F6DC85AQ28677246-3C9CED2C-8740-47B3-A508-68BF67E82765Q29219375-85D38CFD-595E-4DD6-A8AC-D6BD88D2D3F0Q30375300-9A6659AA-1D87-499B-87E2-78D1F00DE45FQ34071946-A3836F67-2F7E-4FD6-8A1C-DE0D21AD2DCCQ35555963-8479D632-2C36-49CB-869D-2F61EC3D50CBQ35877514-75225AB2-87E0-410D-AEFF-04C93CD7941EQ35951079-E1725C8D-B49A-4A05-BC12-3C96F68B9AD5Q35985522-54580654-8291-436F-8B11-D7DBBB80B104Q36014711-82A68F01-FE63-40AE-81AC-0DC636AA9818Q36705799-0FB5FA92-D685-4793-B81C-7D2ABD7D1176Q37640491-C4034876-AE13-4342-8416-9D0B6C01BD35Q38061129-793EB886-0B91-40C8-9BC6-D74EA37D9528Q38125958-1317B274-8627-4603-8BBF-7A9369F3C86FQ38127586-B1565783-3E18-4EE8-B3BE-5BF5CB821432Q38145438-1C6D6C1A-58D2-4643-9829-9D72A2185AA9Q42559945-B3D610EE-28AD-4FF9-8132-9FF916F5CA3EQ42582078-A8C63B78-6E20-497B-A6DE-B870AEAAA92CQ57455337-513B6847-68B5-461D-9BF6-7B6BC74A004CQ58027817-4981F33F-C15A-437E-80B5-B4FDC69014EAQ58851666-58855970-35DC-48D0-B069-BF415A7B211A
P2860
What Information Should Be Required to Support Clinical "Omics" Publications?
description
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
What Information Should Be Required to Support Clinical "Omics" Publications?
@en
What Information Should Be Required to Support Clinical "Omics" Publications?
@nl
type
label
What Information Should Be Required to Support Clinical "Omics" Publications?
@en
What Information Should Be Required to Support Clinical "Omics" Publications?
@nl
prefLabel
What Information Should Be Required to Support Clinical "Omics" Publications?
@en
What Information Should Be Required to Support Clinical "Omics" Publications?
@nl
P1433
P1476
What information should be required to support clinical "omics" publications?
@en
P2093
Keith A Baggerly
P304
P356
10.1373/CLINCHEM.2010.158618
P407
P577
2011-05-01T00:00:00Z